Sunscreen Antiaging Claim Ban Challenged At "Feedback" Meeting
This article was originally published in The Rose Sheet
Sunscreen labeling language should go beyond sunburn prevention use and state the products' protective effects against premature aging and skin damage, industry and medical representatives told FDA at an OTC "feedback" meeting in Rockville, Md July 22.
You may also be interested in...
FDA expressed willingness to reconsider the provision in the sunscreen final monograph that restricts products with sun protection factors over 30 to state only that they are SPF "30 plus."
Sunscreens containing an SPF over 30 will be required to use one collective term, "SPF 30 plus" or "SPF 30+" on labeling under FDA's final sunscreen monograph published in the Federal Register May 21. Due to the projected considerable economic burden on sunscreen manufacturers to comply with the regulation, FDA is extending the proposed 12-month compliance deadline to 24 months (for other provisions, see chart, p. 18).
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program